脑池造瘘术:中重度创伤性颅脑损伤的适时干预——原理、指征与前景
创伤性颅脑损伤(TBI)全球负担重且流行病学三十年无显著变化,原发损伤不可逆,继发损伤决定预后并致颅内压(ICP)升高。现有治疗为阶梯式目标导向的内外科联合方案,包括去骨瓣减压术。随着胶淋巴通路研究与显微外科进步,脑池造瘘术作为新型显微神经外科技术出现,有望管理TBI患者升高的ICP,本文阐述其原理。
要点
- TBI原发损伤不可逆,继发损伤是临床预后关键且可致ICP升高。
- 当前最优管理为阶梯式目标导向的内外科联合治疗,含去骨瓣减压术。
- 脑池造瘘术是新兴显微神经外科技术,有望管理TBI升高的ICP。
核心结论
- 脑池造瘘术作为新兴显微神经外科技术,有望管理中重度TBI患者升高的ICP。
研究设计与样本
- 本文为综述,阐述脑池造瘘术治疗中重度TBI的原理、指征与前景。
主要发现
- TBI流行病学近30年无显著变化,原发损伤不可逆,继发损伤决定临床预后。
- 继发损伤可致ICP升高和进行性神经功能缺损。
- 当前最优管理为阶梯式目标导向的内外科联合策略,包括去骨瓣减压术。
- 胶淋巴通路研究与显微外科进步促成了脑池造瘘术的出现。
临床怎么用
- 对中重度TBI患者,脑池造瘘术可作为管理升高ICP的潜在显微神经外科选择。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Traumatic brain injury (TBI) represents a major public health concern worldwide, with no significant change in its epidemiology over the last 30 years. After TBI, the primary injury induces irreversible brain damage, which is untreatable. The subsequent secondary injury plays a critical role in the clinical prognosis because without effective treatment it will provide additional tissue damage. The resulting scenario is the rise in intracranial pressure (ICP) with the development of progressive neurological deficits. Current optimal management is based on a progressive, target-driven approach combining both medical and surgical treatment strategies among which is decompressive hemicraniectomy. With the advent of technology, research in the glymphatic pathways, and advances in microscopic surgery, a novel surgical technique-the cisternostomy-has emerged that holds promise in managing rising ICP in TBI-affected patients. In this article we describe the rationale for cisternostomy, an emerging microneurosurgical approach for the management of moderate to severe TBI.
引用
- Cherian I, Burhan H, Dashevskiy G, et al. Cisternostomy: A Timely Intervention in Moderate to Severe Traumatic Brain Injuries: Rationale, Indications, and Prospects. World Neurosurg. 2019. PMID: 31658580. doi:10.1016/j.wneu.2019.07.082
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。